Τίτλος:
Antiplatelet and Antithrombotic Therapy in Type I Diabetes Mellitus: Update on Current Data.
Περίληψη:
Diabetes mellitus type 1 (T1DM) is an autoimmune disease characterized by a markedly elevated cardiovascular (CV) risk due to premature atherosclerosis. Previous studies have shown that intense glycemic control reduces the incidence of CV disease. Antiplatelet therapy is considered to be a very important therapy for secondary prevention of recurrent atherothrombotic events in patients with DM, while it may be considered for primary prevention in individuals with T1DM with additional CV risk factors.The aim of the present review is to summarize existing literature data regarding the thrombotic risk in T1DM patients and discuss current treatment strategies.
Συγγραφείς:
Maragkoudakis, Spyridon
Katsi, Vasiliki
Melidonis, Andreas
Soulaidopoulos, Stergios
Kolovou, Genovefa D.
Papazafeiropoulou, Athanasia K.
Trikkalinou, Aikaterini
Toutouzas, Konstantinos
Tsioufis, Constantinos
Περιοδικό:
Current Diabetes Reviews
Λέξεις-κλειδιά:
cardiovascular disease, venous thromboembolism, antiplatelet therapy, antithrombotic therapy, LDL, Type1 diabetes mellitus
DOI:
10.2174/1573399818666220103091236
